|1.||Larauche, M: 1 article (03/2012)|
|2.||Guo, Shi-Gong: 1 article (01/2011)|
|3.||Ma, Sui: 1 article (01/2011)|
|4.||Wang, Zhong: 1 article (01/2011)|
|5.||Qi, Zhi-Wei: 1 article (01/2011)|
|6.||Yu, Xue-Zhong: 1 article (01/2011)|
|7.||Liu, Ye-Cheng: 1 article (01/2011)|
|8.||Pessini, Andréa Carla: 1 article (05/2009)|
|9.||Soares, Denis Melo: 1 article (05/2009)|
|10.||Roth, Joachim: 1 article (05/2009)|
03/01/2012 - "In a recent study in Neurogastroenterology and Motility, van den Wijngaard et al. demonstrate that the mast-cell dependent visceral hypersensitivity observed in maternally separated rats after an acute exposure to a psychological stress can be prevented but not reversed by the peripherally restricted CRF receptor antagonist, α-helical CRF(9-41). "
05/07/2009 - "In contrast, alpha-helical CRF(9-41) (a non-selective CRF R1/R2 receptor antagonist; 25 microg injected i.c.v.) reduced CCL3/MIP-1 alpha-induced fever. "
01/01/2006 - "alpha-Helical CRF(9-41) (dual CRF1/CRF2 receptor antagonist; 6.5 nmol icv) attenuated fever induced by CRF but not by ET-1. "
01/01/1993 - "The intracerebroventricular (I.C.V.) injection of alpha-helical CRF(9-41), a CRF-41 receptor antagonist, significantly attenuated the stress-induced hypertension, tachycardia, hyperthermia and increase in locomotive activity. "
|4.||Hypotension (Low Blood Pressure)
|5.||Hypoglycemia (Reactive Hypoglycemia)
|1.||Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)
|5.||CRF receptor type 2